| scholarly article | Q13442814 |
| P50 | author | Artemis Koukounari | Q59988709 |
| Joanne P. Webster | Q67877771 | ||
| P2093 | author name string | Y Zhang | |
| A C A Clements | |||
| L Blair | |||
| A Fenwick | |||
| J Mwansa | |||
| N B Kabatereine | |||
| F M Fleming | |||
| A F Gabrielli | |||
| A Garba | |||
| E Bosque-Oliva | |||
| J R Stothard | |||
| R Dembele | |||
| S Toure | |||
| U Nyandindi | |||
| P2860 | cites work | Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. | Q38879183 |
| Recent progress in integrated neglected tropical disease control | Q39078147 | ||
| Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. | Q39096377 | ||
| Sustainable schistosomiasis control--the way forward | Q39544924 | ||
| Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso | Q43932581 | ||
| A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: Performance, financial costs and implications for sustainability | Q43933017 | ||
| Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shores in Mwanza District, Tanzania | Q43944611 | ||
| Age and gender effects in self-reported urinary schistosomiasis in Tanzania | Q43944626 | ||
| New initiatives against Africa's worms | Q44641296 | ||
| Control of neglected tropical diseases | Q29547285 | ||
| Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | Q29547716 | ||
| Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa | Q29620602 | ||
| Mapping the probability of schistosomiasis and associated uncertainty, West Africa | Q30485197 | ||
| Towards control of schistosomiasis in sub-Saharan Africa. | Q30862703 | ||
| Schistosomiasis in African infants and preschool children: to treat or not to treat? | Q33269983 | ||
| Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. | Q33296532 | ||
| Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren | Q33338450 | ||
| A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006 | Q33438853 | ||
| Administration of praziquantel to pregnant and lactating women | Q35126809 | ||
| Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. | Q35744749 | ||
| Evaluating the epidemiological impact of national control programmes for helminths | Q35912008 | ||
| Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren | Q36327169 | ||
| Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania | Q36387319 | ||
| Implementation of national schistosomiasis control programmes in West Africa | Q36475694 | ||
| The control of schistosomiasis and soil-transmitted helminths in East Africa | Q36483448 | ||
| A blueprint for success: integration of neglected tropical disease control programmes | Q36483770 | ||
| Schistosomiasis: challenges for control, treatment and drug resistance | Q36639725 | ||
| Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso | Q37113146 | ||
| Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa | Q37123843 | ||
| Immuno-epidemiology of Schistosoma mansoni infections in endemic populations co-infected with soil-transmitted helminths: present knowledge, challenges, and the need for further studies. | Q37201036 | ||
| Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
| Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda | Q38454931 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schistosomiasis | Q221159 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1719-1730 | |
| P577 | publication date | 2009-07-27 | |
| P1433 | published in | Parasitology | Q15753259 |
| P1476 | title | The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. | |
| P478 | volume | 136 |
| Q28539960 | 'Death and axes': unexpected Ca²⁺ entry phenologs predict new anti-schistosomal agents |
| Q89823709 | A Review of Nanotechnology for Targeted Anti-schistosomal Therapy |
| Q38854033 | A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases |
| Q34064528 | A fresh insight into transmission of schistosomiasis: a misleading tale of Biomphalaria in Lake Victoria |
| Q21562257 | A research agenda for helminth diseases of humans: Towards control and elimination |
| Q34222749 | A somatically diversified defense factor, FREP3, is a determinant of snail resistance to schistosome infection. |
| Q28488618 | Accuracy of urine circulating cathodic antigen test for the diagnosis of Schistosoma mansoni in preschool-aged children before and after treatment |
| Q38123553 | Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis |
| Q38852112 | An extensive burden of giardiasis associated with intestinal schistosomiasis and anaemia in school children on the shoreline of Lake Albert, Uganda |
| Q37846890 | Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control |
| Q28547348 | Application of RNAi to Genomic Drug Target Validation in Schistosomes |
| Q46598931 | Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique |
| Q38067995 | Ca²⁺ channels and praziquantel: a view from the free world |
| Q34001292 | Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children |
| Q34675128 | Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine |
| Q37680707 | Community knowledge, attitudes and practices on schistosomiasis in western Kenya--the SCORE Project |
| Q55450344 | Comparative Functional Study of Thioester-containing Related Proteins in the Recently Sequenced Genome of Biomphalaria glabrata. |
| Q54237544 | Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study. |
| Q34431534 | Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections |
| Q28475069 | Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening |
| Q37772261 | Concepts in research capabilities strengthening positive experiences of network approaches by TDR in the People's Republic of China and Eastern Asia |
| Q35040961 | Control efficacy of annual community-wide treatment against Schistosoma japonicum in China: a meta-analysis |
| Q38129110 | Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. |
| Q31159947 | Control of neglected tropical diseases in Burundi: partnerships, achievements, challenges, and lessons learned after four years of programme implementation |
| Q34331536 | Control of neglected tropical diseases needs a long-term commitment |
| Q46964347 | Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. |
| Q37771992 | Controlling schistosomiasis in Southeast Asia: a tale of two countries |
| Q36835774 | Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa |
| Q37715364 | Countrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program. |
| Q37565174 | CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. |
| Q35731580 | Current status of Schistosoma mansoni and the factors associated with infection two years following mass drug administration programme among primary school children in Mwea irrigation scheme: A cross-sectional study |
| Q43924383 | Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis. |
| Q28483732 | Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis |
| Q37330975 | Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali |
| Q37026044 | Deworming the world |
| Q38152776 | Diagnosis and treatment of schistosomiasis in children in the era of intensified control |
| Q35232240 | Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination |
| Q47585899 | Diffusion of treatment in social networks and mass drug administration |
| Q37124226 | Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection |
| Q24201000 | Drugs for treating Schistosoma mansoni infection |
| Q35834575 | Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period |
| Q37740957 | Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa. |
| Q35023664 | Elimination of schistosomiasis transmission in Zanzibar: baseline findings before the onset of a randomized intervention trial |
| Q36045815 | Elimination of urogenital schistosomiasis in Iran: past history and the current situation. |
| Q38725004 | Enhancing collaboration between China and African countries for schistosomiasis control |
| Q33642379 | Epidemiology and control of intestinal schistosomiasis on the Sesse Islands, Uganda: integrating malacology and parasitology to tailor local treatment recommendations |
| Q28538592 | Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis |
| Q34159188 | Epigenetic control of gene function in schistosomes: a source of therapeutic targets? |
| Q36204615 | Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes |
| Q39583417 | Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. |
| Q33847447 | Evaluation of mammalian and intermediate host surveillance methods for detecting schistosomiasis reemergence in southwest China. |
| Q35692538 | Evaluation of point-of-contact circulating cathodic antigen assays for the detection of Schistosoma mansoni infection in low-, moderate-, and high-prevalence schools in western Kenya |
| Q28552287 | Evaluation of the CCA Immuno-Chromatographic Test to Diagnose Schistosoma mansoni in Minas Gerais State, Brazil |
| Q33808771 | Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya |
| Q28475046 | FMRFamide-like peptides (FLPs) enhance voltage-gated calcium currents to elicit muscle contraction in the human parasite Schistosoma mansoni |
| Q37787339 | From innovation to application: Social–ecological context, diagnostics, drugs and integrated control of schistosomiasis |
| Q52716945 | Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. |
| Q34160224 | Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania |
| Q28714178 | Genetic diversity within Schistosoma haematobium: DNA barcoding reveals two distinct groups |
| Q35647661 | Geographical analysis of the role of water supply and sanitation in the risk of helminth infections of children in West Africa |
| Q41719904 | Geostatistical modelling of schistosomiasis prevalence |
| Q34475800 | Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China. |
| Q38205649 | HIV and schistosomiasis co-infection in African children |
| Q28551698 | High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni |
| Q59390076 | Human Schistosomiasis in the Economic Community of West African States |
| Q36210573 | Human schistosome infection and allergic sensitisation |
| Q30372766 | Hyperdiverse gene cluster in snail host conveys resistance to human schistosome parasites |
| Q26825064 | Impact of human schistosomiasis in sub-Saharan Africa |
| Q28481580 | Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali |
| Q30238958 | Implications of Changing Temperatures on the Growth, Fecundity and Survival of Intermediate Host Snails of Schistosomiasis: A Systematic Review |
| Q33630928 | Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination |
| Q50893356 | In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors. |
| Q36660891 | In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates |
| Q35825988 | Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages |
| Q37625862 | Intestinal schistosomiasis in Uganda at high altitude (>1400 m): malacological and epidemiological surveys on Mount Elgon and in Fort Portal crater lakes reveal extra preventive chemotherapy needs |
| Q33734248 | Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity |
| Q33554459 | Knowledge, practices and perceptions of geo-helminthes infection among parents of pre-school age children of coastal region, Kenya. |
| Q57296452 | Low Praziquantel Treatment Coverage for in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance |
| Q55396672 | Low incidence of helminth infections (schistosomiasis, strongyloidiasis, filariasis, toxocariasis) among Dutch long-term travelers: A prospective study, 2008-2011. |
| Q36000293 | Malaria, helminths and malnutrition: A cross-sectional survey of school children in the South-Tongu district of Ghana |
| Q91997221 | Mapping evidence of the concomitant management of schistosomiasis by traditional health practitioners and health care professionals in communities with high prevalent infections: a systematic scoping review protocol |
| Q28478479 | Mapping helminth co-infection and co-intensity: geostatistical prediction in Ghana |
| Q33936776 | Mapping the risk of anaemia in preschool-age children: the contribution of malnutrition, malaria, and helminth infections in West Africa |
| Q28071848 | Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends |
| Q35847008 | Modeling and Validation of Environmental Suitability for Schistosomiasis Transmission Using Remote Sensing |
| Q30485086 | Modelling age-heterogeneous Schistosoma haematobium and S. mansoni survey data via alignment factors |
| Q89578100 | Morbidity and Mortality Due to Schistosoma mansoni Related Periportal Fibrosis: Could Early Diagnosis of Varices Improve the Outcome Following Available Treatment Modalities in Sub Saharan Africa? A Scoping Review |
| Q92499631 | More medicines alone cannot ensure the treatment of neglected tropical diseases |
| Q30378695 | Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies. |
| Q28267545 | Neglected tropical diseases |
| Q35905176 | New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel |
| Q35813630 | New insights into the genetic diversity of Schistosoma mansoni and S. haematobiumin Yemen |
| Q28537580 | New insights into the molecular epidemiology and population genetics of Schistosoma mansoni in Ugandan pre-school children and mothers |
| Q28543650 | No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission area |
| Q28476209 | Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study |
| Q48261649 | Of dogs and hookworms: man's best friend and his parasites as a model for translational biomedical research |
| Q38927082 | One hundred years of neglect in paediatric schistosomiasis |
| Q33778835 | Optimising cluster survey design for planning schistosomiasis preventive chemotherapy |
| Q28538566 | Orally active antischistosomal early leads identified from the open access malaria box |
| Q40045772 | Paediatric and maternal schistosomiasis: shifting the paradigms. |
| Q33784162 | Parasitic worms: knowledge, attitudes, and practices in Western Côte d'Ivoire with implications for integrated control |
| Q34339707 | Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection |
| Q37428688 | Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry |
| Q46249533 | Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme |
| Q35281233 | Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene |
| Q46188046 | Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali. |
| Q33805145 | Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. |
| Q48478674 | Praziquantel: do we need another antischistosoma treatment? |
| Q28541406 | Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium |
| Q36402476 | Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda |
| Q64106115 | Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda |
| Q37683142 | Programmes, partnerships, and governance for elimination and control of neglected tropical diseases |
| Q46326563 | Progress in paediatric parasitology: a preface to a topic focusing on ever younger subjects. |
| Q28485197 | Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection |
| Q35665650 | Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. |
| Q41992861 | Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries |
| Q36089146 | Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration |
| Q34654161 | S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa |
| Q57454628 | Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya |
| Q33796476 | Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable? |
| Q28533358 | Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets |
| Q34899535 | Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum). |
| Q64070759 | Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel |
| Q38495049 | Schistosome sirtuins as drug targets |
| Q33925489 | Schistosomes and snails: a molecular encounter |
| Q33551633 | Schistosomes of small mammals from the Lake Victoria Basin, Kenya: new species, familiar species, and implications for schistosomiasis control. |
| Q82243583 | Schistosomiasis |
| Q37470553 | Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution |
| Q28477431 | Schistosomiasis and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration [corrected] |
| Q42250833 | Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19 |
| Q39031600 | Schistosomiasis elimination: lessons from the past guide the future |
| Q42559175 | Schistosomiasis in Africa: an emerging tragedy in our new global health decade |
| Q37427116 | Schistosomiasis in African infants and preschool children: let them now be treated! |
| Q36454038 | Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy |
| Q33630932 | Schistosomiasis japonica control and research needs |
| Q46431726 | Schistosomiasis research and control since the retirement of Sir Patrick Manson in 1914. |
| Q38376880 | Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt |
| Q28481702 | Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment |
| Q38849543 | Social network fragmentation and community health |
| Q38500836 | Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis |
| Q28551930 | Successful Control of Soil-Transmitted Helminthiasis in School Age Children in Burkina Faso and an Example of Community-Based Assessment via Lymphatic Filariasis Transmission Assessment Survey |
| Q58862731 | Surveillance of intestinal schistosomiasis during control: a comparison of four diagnostic tests across five Ugandan primary schools in the Lake Albert region |
| Q36720951 | Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs |
| Q62077688 | Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as Sm HDAC8 Inhibitors for the Treatment of Schistosomiasis |
| Q28551751 | The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa |
| Q38870767 | The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda |
| Q34570012 | The applications of model-based geostatistics in helminth epidemiology and control |
| Q30388508 | The contribution of mass drug administration to global health: past, present and future |
| Q93099230 | The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda |
| Q33584679 | The evolving schistosomiasis agenda 2007-2017-Why we are moving beyond morbidity control toward elimination of transmission |
| Q27694660 | The roles of water, sanitation and hygiene in reducing schistosomiasis: a review |
| Q35535825 | Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases. |
| Q46226428 | To Reduce the Global Burden of Human Schistosomiasis, Use 'Old Fashioned' Snail Control |
| Q28287833 | Towards improved diagnosis of zoonotic trematode infections in Southeast Asia |
| Q39196853 | Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole community |
| Q54936901 | Treating schistosomiasis among South African high school pupils in an endemic area, a qualitative study. |
| Q33635360 | Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole |
| Q36125948 | Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole |
| Q36338468 | Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study |
| Q92283564 | Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda |
| Q36290950 | Urogenital schistosomiasis and soil-transmitted helminthiasis (STH) in Cameroon: An epidemiological update at Barombi Mbo and Barombi Kotto crater lakes assessing prospects for intensified control interventions |
| Q36450832 | Use of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children |
| Q28477145 | Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review |
| Q28283424 | Which new approaches to tackling neglected tropical diseases show promise? |
| Q21144493 | Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases |
Search more.